Jun 20
|
CureVac Soars 41% in a Month on a $1.25B Buyout Offer From BioNTech
|
Jun 13
|
Oracle reports Q4 beat, BioNTech to acquire CureVac: Morning Buzz
|
Jun 12
|
Stocks to Watch Recap: Boeing, Oracle, GE Aerospace, GameStop
|
Jun 12
|
BioNTech bolsters mRNA pipeline with $1.25bn CureVac acquisition
|
Jun 12
|
Gold prices, BioNTech to acquire CureVac, Tapestry upgrade
|
Jun 12
|
Top Stock Movers Now: Oracle, Boeing, CureVac, and More
|
Jun 12
|
Top Midday Stories: Boeing Shares Fall After Air India Plane Crash; Oracle Q4 Results Top Expectations
|
Jun 12
|
COVID-19 Vaccine Maker BioNTech Buys CureVac as It Aims for Cancer Treatments
|
Jun 12
|
BioNTech to Buy CureVac in $1.25 Billion Deal to Boost Its Cancer Business
|
Jun 12
|
BioNTech to Acquire CureVac in $1.25 Billion All-Stock Deal
|
Jun 12
|
BioNTech buys mRNA, courtroom rival CureVac in all-stock deal
|
Jun 12
|
BioNTech to Acquire CureVac in Stock Deal Valued Around $1.25 Billion
|
Jun 12
|
CureVac stock soars about 30% after BioNTech agrees to acquire co
|
Jun 12
|
BioNTech takes over CureVac in $1.25 billion all-stock deal among COVID rivals
|
May 27
|
We Think CureVac's (NASDAQ:CVAC) Robust Earnings Are Conservative
|
May 26
|
CureVac First Quarter 2025 Earnings: Misses Expectations
|
May 23
|
Earnings Beat: CureVac N.V. (NASDAQ:CVAC) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
|
Apr 17
|
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
|
Apr 14
|
CureVac Among 3 Promising Penny Stocks To Watch
|
Apr 11
|
Prada to acquire Versace, CarMax reports mixed Q4 results: Morning Buzz
|